| Literature DB >> 29524049 |
D Lewczuk1, A Bereznowski2, M Hecold2, M Frąszczak3, A Ruść4, A Korwin-Kossakowska5, J Szyda3, S Kamiński4.
Abstract
Horses lose potential opportunities because of health problems. Available breeding strategies are not effective enough, probably also because of the different definition used and its genetic usefulness. The aim of the study was to compare the genetic background estimated by the genome-wide association study (GWAS) for osteochondrosis using two different scaling osteochondrosis (OC)/healthy and osteochondrosis dissecans (OCD)/healthy systems for evaluating the disease status of investigated fetlock joints. Two hundred one Warmblood horses trained for performance tests (87 stallions and 114 mares) were phenotyped and genotyped. Four fetlock x-ray images per horse were collected using the RTG Girth HF 80 and Vet Scan ray 3600. The DNA of each horse was genotyped using the BeadChip 70K. To identify SNPs that significantly affect the probability of osteochondrosis, two different methods were applied: the Cochran-Armitage test based on an additive mode of inheritance and logistic regression. The genetic background for osteochondrosis, expressed in the number of SNPs found with significant associations with osteochondrosis, was higher by evaluation in the scale of OCD/healthy horses (16 SNPs on several chromosomes mainly on the ECA1 and ECA10) than OC/healthy (2 SNPs on the ECA15 and one SNP on the ECA10). Detailed definition of osteochondrosis is needed in breeding and in veterinary practice. The genetic background for osteochondrosis and osteochondrosis dissecans seems not the same. Suggestive SNPs could be the candidate markers for osteochondrosis but should be checked on a larger population before usage.Entities:
Keywords: GWAS; Horse; Osteochondrosis definition; Selection
Mesh:
Year: 2018 PMID: 29524049 PMCID: PMC5895668 DOI: 10.1007/s13353-018-0437-6
Source DB: PubMed Journal: J Appl Genet ISSN: 1234-1983 Impact factor: 3.240
SNPs statistically significant for the evaluation of OCD for the fetlock joint (metacarpal phalangeal/metatarsal phalangeal)
| System OCD (only osteochondrosis dissecans treated as ill) | ||
|---|---|---|
| SNP identification | Position | |
| BIEC2_22135 | 4.20E−02 | (1) 52.99 |
| BIEC2_490019 | 3.17E−02 | (2) 76.23 |
| BIEC2_1008454 | 7.8E−04 | (7) 82.05 |
| BIEC2_102646 | 3.17E−02 | (10) 7.89 |
| BIEC2_130298 | 2.05E−07 | (10) 66.96 |
| BIEC2_130301 | 2.05E−07 | (10) 66.96 |
| BIEC2_141465 | 2.34E−02 | (11) 3.24 |
| BIEC2_408453 | 2.03E−03 | (18) 20.52 |
| BIEC2_409553 | 3.49E−02 | (18) 26.44 |
| BIEC2_430250 | 2.80E−02 | (19) 15.53 |
| BIEC2_524840 | 9.91E−04 | (20) 23.37 |
| BIEC2_630333 | 2.34E−02 | (24) 6.21 |
| BIEC2_1116623 | 2.37E−02 | (X) 26.85 |
| BIEC2_29595 | 1.46E−02 | (1) 70.95 |
| BIEC2_30646 | 1.51E−02 | (1) 69.45 |
| BIEC2_579755 | 1.05E−02 | (22) 8.49 |
BIEC2: names of the SNPs given by the Illumina BeadChip producer
ECA equine chromosome
SNPs statistically significant for the evaluation of OC for the fetlock joint (metacarpal phalangeal/metatarsal phalangeal)
| System OC (all signs of illness treated as ill) | ||
|---|---|---|
| SNP identification | Position | |
| BIEC2_137996 | 2.25E−02 | (10) 72.68 |
| BIEC2_323837 | 4.10E−02 | (15) 82.17 |
| BIEC2_323907 | 1.96E−02 | (15) 82.29 |
Comparison of SNP positions statistically significant for OCD in various studies and our results
| ECA | SNPs at positions [Mb] | Author | Our SNPs at positions [Mb] | Joint |
|---|---|---|---|---|
| 1 | 160.5 | Lykkjen et al. | 70.95; 69.45 | Fetlock |
| 139.7 | Lykkjen et al. | Fetlock | ||
| 3 | 105.2–105.8 | Orr et al. | Hock | |
| 113.5 | Teyssedre et al. | Hock | ||
| 103.4–107.9 | Teyssèdre et al. | Hock | ||
| 88.5 | Corbin et al. | Stifle | ||
| 4 | 39.26 | Corbin et al. | Hock | |
| 5 | 42.5 | Lykkjen et al. | Hock | |
| 7 | 69.6 | Lykkjen et al. | 44.3 | Fetlock |
| 15 | 87.3 | Teyssedre et al. | 82.17–82.29 | Fetlock |
| 10 | 60.5 | Lykkjen et al. | Hock | |
| 48.25–48.33 | Orr et al. | Hock | ||
| 11 | 10.9 | Lykkjen et al. | 3.24 | Fetlock |
| 14 | 67.97–77.90 | Teyssèdre et al. | Hock | |
| 18 | 36.77 | Corbin et al. | Hock |